Molecular analysis of streptogramin resistance in enterococci

https://doi.org/10.1078/1438-4221-00194Get rights and content

Abstract

The new semi-synthetic streptogramin antibiotic combination quinupristin/dalfopristin (Synercid®) is a promising alternative for a treatment of infections with multiple resistant gram-positive pathogens, e.g. glycopeptide- and multi-resistant Enterococcus faecium. Streptogramins consist of two unrelated compounds, a streptogramin A and B, which act synergistically when given in combination. Mechanisms conferring resistance against both components are essential for resistance against the combination in E. faecium. In this species resistance to streptogramin A compounds is mediated via related acetyltransferases VatD and VatE. Resistance against streptogramins B is either encoded by the widespread ermB gene cluster conferring resistance to macrolide-lincosamide-streptogramin B antibiotics or via expression of the vgbA gene, which encodes a staphylococcal-type lactonase. E. faecalis is intrinsically resistant to streptogramins. Due to a wide use of streptogramins (virginiamycins S/M) in commercial animal farming a reservoir of streptogramin-resistant E. faecium isolates had already been selected. Determinants for streptogramin resistance are localized on plasmids that can be transferred into an E. faecium recipient both in vitro in filter-matings and in vivo in the digestive tracts of rats. Hybridization and sequencing experiments revealed a linkage of resistance determinants for streptogramins A and B on definite plasmid fragments.

References (112)

  • G. Lodder et al.

    Molecular analysis of naturally occurring ermC-encoding plasmids in staphylococci isolates from animals with and without previous contact to macrolide/lincosamide antibiotics

    FEMS Immunol. Med. Microbiol.

    (1997)
  • B. Martin et al.

    Constitutive expression of erythromycin resistance mediated by the erm AM determinant of plasmid pAMβ1 results from deletion of 5' leader peptide sequences

    Plasmid

    (1987)
  • J. Millichap et al.

    Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP59500 using stepwise in vitro exposure

    Diagn. Microbiol. Infect. Dis.

    (1996)
  • I.D. Milton et al.

    Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus

    FEMS Microbiol. Lett

    (1992)
  • A. Pantosti et al.

    Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban

    Lancet

    (1999)
  • B.T. Porse et al.

    Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23S rRNA and the synergism of their inhibitory mechanisms

    J. Mol. Biol.

    (1999)
  • F.M. Aarestrup et al.

    Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark

    Antimicrob. Agents Chemother.

    (2001)
  • F.M. Aarestrup

    Characterization of glycopeptide-resistant Enterococcus faecium (GRE)from broilers and pigs in Denmark: Genetic evidence that persistence of GRE in pig herds is associated with co-selection by resistance to macrolides

    J. Clin. Microbiol.

    (2000)
  • J. Allignet et al.

    Diversity among the Gram positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB

    Antimicrob. Agents Chemother.

    (1995)
  • J. Allignet et al.

    Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB encoding resistance to streptogramins A and B and similar antibiotics

    Antimicrob. Agents Chemother.

    (1998)
  • M. Aumercier et al.

    Irreversible binding of pristinamycin IIA (streptogramin A)to ribosomes explains its “lasting damage” effect

    J. Antibiot.

    (1986)
  • M. Aumercier et al.

    RP59500:A proposed mechanism for its bacterial activity

    J. Antimicrob. Chemother

    (1992)
  • J.C. Barrière et al.

    Recent developments 90 G

    Werner et al. in streptogramin research. Curr. Pharmaceut. Res.

    (1998)
  • M. Bergeron et al.

    The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans

    J. Antimicrob. Chemother

    (1997)
  • D. Beyer et al.

    The streptogramin antibiotics: update on their mechanism of action

    Exp. Opin. Invest. Drugs

    (1998)
  • D.H. Bouanchaud

    In vitro and in vivo activity of quinupristin/dalfopristin

    J. Antimicrob. Chemother

    (1997)
  • B. Bozdogan et al.

    Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin/dalfopristin against Enterococcus faecium

    Antimicrob. Agents Chemother.

    (1999)
  • Bozdogan et al.

    Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032

    Antimicrob. Agents Chemother.

    (1999)
  • A. Casetta et al.

    Diversity of structures carrying the high-level gentamicin resistance gene (aaco6-aph2)in Enterococcus faecalis strains isolated in France

    Antimicrob. Agents Chemother.

    (1998)
  • J. Chow et al.

    Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals of two states

    J. Clin. Microbiol.

    (1993)
  • K. Dahl et al.

    In vivo transfer of the vanA gene cluster in the intestinal tract of germfree animals

    Clin. Microbiol. Infect.

    (1999)
  • DANMAP 2000. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food...
  • DANMAP 98. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food...
  • DANMAP 99. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food...
  • L.A. Devriese

    In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds

    Ann. Rech. Vet.

    (1976)
  • M. Di Giambattista et al.

    The molecular basis of the inhibitory activities of type A and B synergimycins and related antibiotics on ribosomes

    J. Antimicrob. Chemother.

    (1989)
  • A. Dublanchet et al.

    Resistance to streptogramin antibiotics in Staphylococcus aureus

    Ann. Microbiol.

    (1977)
  • E.A. Eady et al.

    Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump n epidemiologically distinct groups of staphylococci

    J. Antimicrob. Chemother.

    (1993)
  • W.B. Furlong et al.

    Therapy with RP59500 (quinupristin/dalfopristin)for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns

    Clin. Infect. Dis.

    (1997)
  • A.M. Hammerum et al.

    Indication of transposition of a mobile DNA element containing the vat(D) and erm(B)genesin Enterococcus faecium

    Antimicrob. Agents Chemother.

    (2001)
  • A.M. Hammerum et al.

    Characterization of vancomycin-suscep-tible Enterococcus faecium isolates from humans, chickens, and pigs by ribo-printing and pulsed-field gel electrophoresis

    J. Antimicrob. Chemother.

    (2000)
  • J. Hanrahan et al.

    Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains

    Antimicrob. Agents Chemother.

    (2000)
  • J. Haroche et al.

    satG, conferring resistance to streptogramin A, is widely distributed in Enterococcus faecium strains but not in taphylococci

    Antimicrob. Agents Chemother.

    (2000)
  • J. Haroche et al.

    Characterization of a variant of vga(A)conferring resistance to streptogramin A and related compounds

    Antimicrob. Agents Chemother.

    (2000)
  • J.E. Henney

    First antibacterial for VREF

    J. Am. Med. Assoc.

    (1999)
  • D.G. Higgins et al.

    Fast and sensitive multiple sequence alignments on a microcomputer

    Comput. Appl. Biosci.

    (1989)
  • W.L. Homan et al.

    A multi locus sequence typing scheme for Enterococcus faecium

    J. Clin. Microbiol.

    (2002)
  • S. Horinouchi et al.

    A complexattenuator regulates inducible resistance to macro ides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis

    J. Bacteriol.

    (1983)
  • B.L. Jacobsen et al.

    Horizontal transfer of the satA gene encoding streptogramin A resistance between isogenic Enterococcus faecium strains in the gastrointestinal tract of gnotobiotic rats

    Microb. Ecol. Health Dis.

    (1999)
  • L.B. Jensen et al.

    Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in The Netherlands

    Antimicrob. Agents Chemother.

    (1998)
  • Cited by (34)

    • Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century

      2016, Infectious Disease Clinics of North America
      Citation Excerpt :

      Reduced susceptibility to Q/D in E faecium is mediated by several mechanisms. First, modification of dalfopristin via the acetyltransferases VatD and VatE reduces binding affinity owing to steric hindrance, disrupting the bactericidal synergy of the 2 compounds.106 Enzymatic cleavage of the ring structure of quinupristin by the lactonases VgbA and VgbB, originally described in staphylococci, leads to inactivation of the compound.107

    • Antibiotic resistant enterococci-Tales of a drug resistance gene trafficker

      2013, International Journal of Medical Microbiology
      Citation Excerpt :

      Therapeutic alternatives to treat infections with multi- and vancomycin-resistant enterococci (VRE) are limited to antibiotics of last resort (quinupristin/dalfopristin, linezolid, tigecycline, daptomycin). However, they are only approved for certain indications, and resistances to those drugs have already been reported (Arias et al., 2011; Werner et al., 2002, 2008b). From a medical perspective acquired resistance to glycopeptides (vancomycin/teicoplanin; genotypes vanA-N) is the key resistance trait in enterococci, as is the case for methicillin resistance in S. aureus (Courvalin, 2006; Werner, 2012).

    • Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium

      2010, Clinical Microbiology and Infection
      Citation Excerpt :

      Several mechanisms of acquired Q/D resistance have been described in E. faecium, including 23S rRNA gene methylation, enzymatic inactivation of streptogramin A and efflux pumps [133,134]. Enterococcal plasmids harbouring vat(D) and vat(E) determinants encoding acetyltransferases and determinants for MLSB resistance inactivating streptogramins A and B have been described [135–137]. Only sporadic enterococcal isolates with phenotypic intermediate or borderline resistance (MIC = 0.5/≥1 mg/L) are reported in larger clinical trials.

    • Prevalence of streptogramin resistance in enterococci from animals: identification of vatD from animal sources in the USA

      2007, International Journal of Antimicrobial Agents
      Citation Excerpt :

      Southern analysis of the plasmids using a vatD probe revealed that the gene was located on plasmids, suggesting that dissemination of vatD among enterococci may be possible, although at low frequency. Results from this study indicate that Q/D resistance among enterococci from animal and environmental sources may not be as prevalent as previously reported [10,36]. It is interesting to note that even with the long history of virginiamycin use in animals, genes mediating resistance to Q/D were not widespread among the isolates.

    View all citing articles on Scopus
    View full text